Immune-Related Adverse Drug Reactions and Immunologically Mediated Drug Hypersensitivity
- PMID: 33012325
- DOI: 10.1016/j.iac.2020.06.003
Immune-Related Adverse Drug Reactions and Immunologically Mediated Drug Hypersensitivity
Abstract
Biologic and other therapies used for the treatment of immune-mediated hypersensitivity conditions, and in people with immune-mediated hypersensitivity, can trigger a wide variety of immune-related adverse drug reactions and immunologically mediated drug hypersensitivities. These range from acute-onset immunoglobulin E-mediated allergies to delayed-onset T-cell-mediated hypersensitivities. Certain therapeutic and diagnostic agents can directly activate mast cells. Biologic agents used to treat immune-mediated hypersensitivity can also globally upregulate or downregulate the immune system leading to pathologic reactions, including cytokine storm and hypogammaglobulinemia.
Keywords: Adenovirus vector; Adverse drug reaction; Allergy; Complement; Cytokine storm; Gene transfer; Hypersensitivity; Hypogammaglobulinemia.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure E. Macy has received research grants to study drug allergy from ALK. He has served on data and safety monitoring boards for BioMarin and Audentes. He has performed consulting for Kalobios and Audentes. He is a member of the Ask an Expert Panel of the American Academy of Allergy, Asthma, and Immunology.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
